The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

about

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

Item

http://www.wikidata.org/entity/Q57816736

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@en

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@nl

type

Item

label

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@en

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@nl

prefLabel

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@en

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@nl

P1476

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes

@en

P2093

Ken Coppieters

http://www.w3.org/2001/XMLSchema#string

Matthias von Herrath

http://www.w3.org/2001/XMLSchema#string

P2860

Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies

Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study

Genetic and epigenetic fine mapping of causal autoimmune disease variants

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.

Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.

P304

283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2018.00283

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30356664

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

immunotherapy

P932

6189286

http://www.w3.org/2001/XMLSchema#string